Latest Walgreens stock price forecast incorporates healthcare services expansion, which could unlock new revenue streams, driving valuations toward $25 by year-end based on current cash flow projections. Every investor in Walgreens Boots Alliance, Inc. ( NASDAQ:WBA ) should be aware of the most powerful shareholder groups. The group holding the most number of shares in the company, around 62% to be precise, is institutions. Put another way, the group faces the maximum upside potential (or downside risk). But there’s been no serious opposition that has emerged to the purchase by Sycamore, which is paying $11.45 per share — 29% above the December stock price. Sycamore also agreed to “one non-transferable right" to receive up to $3 in cash per Walgreens share “from the future monetization of WBA’s debt and equity interests in VillageMD, which includes the Village Medical, Summit Health and CityMD businesses,” the companies said of Walgreens’ primary care businesses. Walgreens stock price forecast remains sensitive to healthcare policy changes, with regulatory clarity likely to lift sentiment, offering a pathway toward a $22.80 short-term price target.